Recent studies have demonstrated that UBQLN1 can inhibit apoptosis in lung cancer cells by stabilizing Bcl-B, and Bcl-2 family protein [6]; Ubiquilin can increase expression of p53 by affecting the degradation of p53 in a UBA domain-dependent manner [7, 8]. Here, TP53 is linked to lung cancer.